458 related items for PubMed ID: 18465150
1. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150
[Abstract] [Full Text] [Related]
2. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J, Du J, Wang S, Xiao L, Zhao X.
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[Abstract] [Full Text] [Related]
3. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
4. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug 01; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
5. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.
Nephrol Dial Transplant; 2012 Mar 01; 27(3):1083-9. PubMed ID: 21810762
[Abstract] [Full Text] [Related]
6. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.
Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM.
Clin J Am Soc Nephrol; 2011 Jun 01; 6(6):1308-15. PubMed ID: 21566104
[Abstract] [Full Text] [Related]
7. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
Pediatr Nephrol; 2016 Jan 01; 31(1):89-95. PubMed ID: 26341251
[Abstract] [Full Text] [Related]
8. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2010 Mar 01; 25(3):539-44. PubMed ID: 20049616
[Abstract] [Full Text] [Related]
9. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
Eur J Pediatr; 2013 Apr 01; 172(4):513-8. PubMed ID: 23271494
[Abstract] [Full Text] [Related]
10. Novel use of rituximab for steroid-dependent nephrotic syndrome in children.
Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, Kaneko K.
Am J Nephrol; 2013 Apr 01; 38(6):483-8. PubMed ID: 24296765
[Abstract] [Full Text] [Related]
11. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
Pediatr Nephrol; 2013 Feb 01; 28(2):257-64. PubMed ID: 23052656
[Abstract] [Full Text] [Related]
12. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
Hoseini R, Sabzian K, Otukesh H, Zafaranloo N, Panahi P, Rahimzadeh N, Nakhaie S, Akhavan Sepehi M.
Iran J Kidney Dis; 2018 Jan 01; 12(1):27-32. PubMed ID: 29421774
[Abstract] [Full Text] [Related]
13. Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis.
Suyama K, Kawasaki Y, Miyazaki K, Kanno S, Ono A, Suzuki Y, Ohara S, Hosoya M.
Pediatr Int; 2016 Mar 01; 58(3):219-223. PubMed ID: 26275234
[Abstract] [Full Text] [Related]
14. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
Kronbichler A, König P, Busch M, Wolf G, Mayer G, Rudnicki M.
Wien Klin Wochenschr; 2013 Jun 01; 125(11-12):328-33. PubMed ID: 23624956
[Abstract] [Full Text] [Related]
15. Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T.
Pediatr Nephrol; 2013 Mar 01; 28(3):447-51. PubMed ID: 23212560
[Abstract] [Full Text] [Related]
16. Rituximab in adult patients with immunosuppressive-dependent minimal change disease.
Hoxha E, Stahl RA, Harendza S.
Clin Nephrol; 2011 Aug 01; 76(2):151-8. PubMed ID: 21762648
[Abstract] [Full Text] [Related]
17. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.
Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.
Nephrol Dial Transplant; 2014 Nov 01; 29(11):2084-91. PubMed ID: 24920841
[Abstract] [Full Text] [Related]
18. Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, Cailliez M, Pietrement C, Dunand O, Nathanson S, Bertholet-Thomas A, Ichay L, Decramer S.
Pediatr Nephrol; 2013 Jun 01; 28(6):911-8. PubMed ID: 23340857
[Abstract] [Full Text] [Related]
19. Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.
Ghiggeri GM, Musante L, Candiano G, Bruschi M, Santucci L, Barbano G, Trivelli A, Rivabella L, Gusmano R, Perfumo F.
Pediatr Nephrol; 2007 Nov 01; 22(11):1953-6. PubMed ID: 17661091
[Abstract] [Full Text] [Related]
20. Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Delbet JD, Leclerc G, Ulinski T.
Pediatr Nephrol; 2019 Mar 01; 34(3):529-532. PubMed ID: 30542932
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
